Reactive arthritis induced by active extra-articular tuberculosis

• Endo, Yushiro

• Kawashiri, Shin-ya

• Koga, Tomohiro

• Okamoto, Momoko

• Tsuji, Sosuke

• Takatani, Ayuko

• Shimizu, Toshimasa

• Sumiyoshi, Remi

• Igawa, Takashi

• Iwamoto, Naoki

• Ichinose, Kunihiro

• Tamai, Mami

• Nakamura, Hideki

• Origuchi, Tomoki

• Kawakami, Atsushi

Abstract

RATIONALE: Rare cases of reactive arthritis induced by active extra-articular tuberculosis (Poncet disease) have been reported. Complete response to antitubercular treatment and evidence of active extra-articular tuberculosis are the most important clinical features of Poncet disease. We report the case of successfully treated a patient with reactive arthritis induced by active extra-articular tuberculosis with a TNF inhibitor after sufficient antitubercular treatment. PATIENT CONCERNS: A 56-year-old Japanese man was admitted to our department with polyarthralgia, low back pain, and high fever. The results of rheumatoid factor, anti-citrullinated protein antibody, human leukocyte antigen B27, and the assays for the detection of infections (with an exception of T-SPOT.TB) were all negative. Fluoro-deoxy-D-glucose-positron emission tomography with CT (PET/CT) showed moderate uptake in the right cervical, right supraclavicular, mediastinal, and abdominal lymph nodes. As magnetic resonance imaging and power Doppler ultrasonography showed peripheral inflammation (tendinitis, tenosynovitis, ligamentitis, and enthesitis in the limbs). DIAGNOSIS: A diagnosis of tuberculous lymphadenitis was eventually established on the basis of lymph node biopsy results. There was no evidence of a bacterial infection including acid-fast bacteria in his joints, and the symptoms of polyarthralgia and low back pain were improved but not completely resolved with NSAID therapy; in addition, a diagnosis of reactive arthritis induced by active extraarticular tuberculosis was made. INTERVENTIONS: The patient experienced persistent peripheral inflammation despite antitubercular treatment for more than nine months and was then successfully treated with a tumor necrosis factor inhibitor (adalimumab 40 mg every 2 weeks). OUTCOMES: Finally, the patient responded to the treatment and has been in remission for over 4 months as of this writing. LESSONS: In patients who present with symptoms associated with spondyloarthritis, it is important to distinguish between classic reactive arthritis and reactive arthritis induced by extra-articular tuberculosis infection. Introduction of biological agents should be carefully considered in settings where reactive arthritis induced by active extra-articular tuberculosis shows progression to chronicity despite sufficient antitubercular treatment.

Medicine, 98(49), e18008; 2019

Journal

• Medicine

  Medicine 98 (49), e18008-, 2019-12

  Wolters Kluwer Health, Inc.

Keywords

• Poncet disease
• reactive arthritis
• spondyloarthritis
• tuberculosis

Details

• CRID: 1050568772240719232
• NII Article ID: 120006988344
• ISSN: 00257974
• ISSN: 15365964
• DOI: 10.1097/md.0000000000018008
• HANDLE: 10069/39602
• Web Site: https://nagasaki-u.repo.nii.ac.jp/records/437
• Web Site: https://journals.lww.com/10.1097/MD.0000000000018008
• Text Lang: en
• Article Type: journal article
• Data Source:
  • IRDB
  • Crossref
  • CiNii Articles
  • KAKEN